1. Home
  2. SCOR vs AARD Comparison

SCOR vs AARD Comparison

Compare SCOR & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo comScore Inc.

SCOR

comScore Inc.

HOLD

Current Price

$4.89

Market Cap

101.6M

ML Signal

HOLD

Logo Aardvark Therapeutics Inc.

AARD

Aardvark Therapeutics Inc.

N/A

Current Price

$5.06

Market Cap

107.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCOR
AARD
Founded
1999
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.6M
107.7M
IPO Year
2007
2025

Fundamental Metrics

Financial Performance
Metric
SCOR
AARD
Price
$4.89
$5.06
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$15.29
AVG Volume (30 Days)
44.4K
132.0K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
127.37
43.11
EPS
N/A
N/A
Revenue
$403,549,000.00
N/A
Revenue This Year
$2.75
N/A
Revenue Next Year
$7.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.02
N/A
52 Week Low
$4.60
$3.35
52 Week High
$10.18
$17.94

Technical Indicators

Market Signals
Indicator
SCOR
AARD
Relative Strength Index (RSI) 40.06 45.27
Support Level $4.60 $4.99
Resistance Level $7.72 $6.01
Average True Range (ATR) 0.39 0.69
MACD 0.06 -0.12
Stochastic Oscillator 42.76 36.46

Price Performance

Historical Comparison
SCOR
AARD

About SCOR comScore Inc.

comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.

About AARD Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Share on Social Networks: